Key Highlights: Implications: India-specific models target the $1.68B cardiovascular devices/diagnostics market (8.5% CAGR to $2.53B by 2031), shifting Narayana’s 60K+ annual procedu...
Home / SouthAsianHealth
Browsing Tag: SouthAsianHealth
Featured Posts
1
Top 10 Indian BioPharma Companies of 2026
July 28, 20262
3
Sun Pharmaceutical Industries
July 27, 2026